1-1 of 1
Huijuan Zhong
Close
Sort by
Journal Articles

Additional Two Cycles of Rituximab Improves the Prognosis of Low-Risk NCCN-IPI Diffuse Large B-Cell Lymphoma Patients Responded to R-CHOP Regimen

Pengpeng Xu, Huijuan Zhong, Weili Zhao, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2733.
https://doi.org/10.1182/blood.V126.23.2733.2733
Published: 2015